IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,365,477 | +433.4% | 61,617 | +163.6% | 0.00% | – |
| Q2 2023 | $443,500 | -43.5% | 23,379 | -53.8% | 0.00% | – |
| Q1 2023 | $785,194 | +46.5% | 50,625 | +66.3% | 0.00% | – |
| Q4 2022 | $536,124 | +379.9% | 30,434 | +50.1% | 0.00% | – |
| Q1 2022 | $111,721 | -46.5% | 20,276 | -17.3% | 0.00% | – |
| Q4 2021 | $209,000 | -1.4% | 24,511 | +0.4% | 0.00% | – |
| Q3 2021 | $212,000 | -10.5% | 24,424 | +9.0% | 0.00% | – |
| Q2 2021 | $237,000 | -34.9% | 22,413 | -1.2% | 0.00% | – |
| Q1 2021 | $364,000 | -65.2% | 22,679 | +0.2% | 0.00% | -100.0% |
| Q4 2020 | $1,045,000 | +55.3% | 22,628 | +18.4% | 0.00% | 0.0% |
| Q3 2020 | $673,000 | +137.8% | 19,117 | +72.0% | 0.00% | – |
| Q2 2020 | $283,000 | – | 11,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |